Cognate was formed to provide a broad range of preclinical and clinical services to biotechnology companies and large pharma. Cognate applies the know-how and expertise of its scientific and technical teams to successfully develop biotechnology products across multiple cell-based technology platforms. Cognate's preclinical team works with clients to support planning, performance and analysis of preclinical studies.
For more information on our Preclinical Services, please click here (PDF File).